journal logo

Welcome to Blood Cancer Journal

A peer-reviewed fully open access journal dedicated to publishing articles of the highest quality related to hematologic malignancies and related disorders

Announcements

  • algorithm image

    Blood Cancer Journal proudly publishes ‘Current Treatment Algorithms’, an article type dedicated to providing clear, authoritative, concise treatment pathways for hematologic malignancies. Read the full series here.

  • image

    Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM) Listen to the authors of this article discussing their recommendations for the assessment and management of belamaf-associated ocular events to help mitigate ocular risk and enable patients to continue to experience a clinical benefit with belamaf.

  • BCJ Twitter Logo

    Join the Blood Cancer Journal Twitter Community

  • @BloodCancerJnl
  • Follow us to keep up-to-date with the latest research and news from Blood Cancer Journal. Share your views, retweet and give us feedback.

Advertisement

Current Treatment Algorithms

A new year brings a new series for Blood Cancer Journal - January 2018 sees the launch of a new article type called ‘Current Treatment Algorithms’, a new series dedicated to providing clear, authoritative, concise treatment pathways for hematologic malignancies.
Collection

Advertisement